{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:23:31Z","timestamp":1773296611799,"version":"3.50.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1093\/jac\/dkl015","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T02:41:30Z","timestamp":1139366490000},"page":"732-740","source":"Crossref","is-referenced-by-count":43,"title":["Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis"],"prefix":"10.1093","volume":"57","author":[{"given":"Wim","family":"van Vianen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siem","family":"de Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian T.","family":"ten Kate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron A. A.","family":"Mathot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma A. J. M.","family":"Bakker-Woudenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,2,7]]},"reference":[{"key":"key\n\t\t\t\t20171012173846_B1","doi-asserted-by":"crossref","unstructured":"Letcher-Bru V. Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother2003; 51: 513\u201321.","DOI":"10.1093\/jac\/dkg117"},{"key":"key\n\t\t\t\t20171012173846_B2","doi-asserted-by":"crossref","unstructured":"Groll AH, Shah PM, Mentzel C et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect1996; 33: 23\u201332.","DOI":"10.1016\/S0163-4453(96)92700-0"},{"key":"key\n\t\t\t\t20171012173846_B3","doi-asserted-by":"crossref","unstructured":"Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis2003; 36: 1445\u201357.","DOI":"10.1086\/375080"},{"key":"key\n\t\t\t\t20171012173846_B4","doi-asserted-by":"crossref","unstructured":"Maertens J, Glasmacher A, Selleslag D et al. Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillus study. Clin Infect Dis2005; 41: e9\u201314.","DOI":"10.1086\/430826"},{"key":"key\n\t\t\t\t20171012173846_B5","doi-asserted-by":"crossref","unstructured":"Branch RA. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation. Arch Intern Med1988; 148: 2389\u201394.","DOI":"10.1001\/archinte.1988.00380110049010"},{"key":"key\n\t\t\t\t20171012173846_B6","doi-asserted-by":"crossref","unstructured":"Warnock, DW. Amphotericin B: an introduction. J Antimicrob Chemother1991; 28: 27\u201338.","DOI":"10.1093\/jac\/28.suppl_B.27"},{"key":"key\n\t\t\t\t20171012173846_B7","doi-asserted-by":"crossref","unstructured":"Herbrecht, R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med2002; 347: 408\u201315.","DOI":"10.1056\/NEJMoa020191"},{"key":"key\n\t\t\t\t20171012173846_B8","doi-asserted-by":"crossref","unstructured":"Sable CA, Nguyen BYT, Chodakewitz JA et al. Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Transpl Infect Dis2002; 4: 25\u201330.","DOI":"10.1034\/j.1399-3062.2002.01004.x"},{"key":"key\n\t\t\t\t20171012173846_B9","doi-asserted-by":"crossref","unstructured":"Lewis RE, Wiederhold NP, Klepser ME. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Antimicrob Agents Chemother2005; 49: 945\u201351.","DOI":"10.1128\/AAC.49.3.945-951.2005"},{"key":"key\n\t\t\t\t20171012173846_B10","doi-asserted-by":"crossref","unstructured":"Meletiadis J, Mouton JW, Meis JFG et al. Eurofung network. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol2001; 39: 3402\u20138.","DOI":"10.1128\/JCM.39.9.3402-3408.2001"},{"key":"key\n\t\t\t\t20171012173846_B11","unstructured":"Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard M38-A. CLSI, Wayne, PA, USA, 2005."},{"key":"key\n\t\t\t\t20171012173846_B12","doi-asserted-by":"crossref","unstructured":"Maertens J, Raad I, Petrikkos G et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis2004; 39: 1563\u201371.","DOI":"10.1086\/423381"},{"key":"key\n\t\t\t\t20171012173846_B13","doi-asserted-by":"crossref","unstructured":"Abruzzo GK, Gill CJ, Flatterly AM et al. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice. Antimicrob Agents Chemother2000; 44: 2310\u201318.","DOI":"10.1128\/AAC.44.9.2310-2318.2000"},{"key":"key\n\t\t\t\t20171012173846_B14","doi-asserted-by":"crossref","unstructured":"Bowman JC, Abruzzo GK, Anderson JW et al. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob Agents Chemother2001; 45: 3474\u201381.","DOI":"10.1128\/AAC.45.12.3474-3481.2001"},{"key":"key\n\t\t\t\t20171012173846_B15","doi-asserted-by":"crossref","unstructured":"Imai J, Singh G, Fernandez B et al. Efficacy of Abelcet and Caspofungin, alone or in combination, against CNS aspergillosis in a murine model. J Antimicrob Chemother2005; 56: 166\u201371.","DOI":"10.1093\/jac\/dki178"},{"key":"key\n\t\t\t\t20171012173846_B16","doi-asserted-by":"crossref","unstructured":"Kirkpatrick WR, Perea S, Coco BJ et al. Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother2002; 46: 2564\u201368.","DOI":"10.1128\/AAC.46.8.2564-2568.2002"},{"key":"key\n\t\t\t\t20171012173846_B17","doi-asserted-by":"crossref","unstructured":"Petraitiene R, Petraitis V, Groll AH et al. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob Agents Chemother2002; 46: 12\u201323.","DOI":"10.1128\/AAC.46.1.12-23.2002"},{"key":"key\n\t\t\t\t20171012173846_B18","doi-asserted-by":"crossref","unstructured":"Wiederhold NP, Kontoyiannis DP, Jingduan C et al. Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J Infect Dis2004; 190: 1464\u201371.","DOI":"10.1086\/424465"},{"key":"key\n\t\t\t\t20171012173846_B19","doi-asserted-by":"crossref","unstructured":"Becker MJ, de Marie S, Fens MHAM et al. Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis. J Antimicrob Chemother2003; 52: 428\u201334.","DOI":"10.1093\/jac\/dkg367"},{"key":"key\n\t\t\t\t20171012173846_B20","doi-asserted-by":"crossref","unstructured":"Becker MJ, de Marie S, Willemse D et al. Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol2000; 38: 1434\u20138.","DOI":"10.1128\/JCM.38.4.1434-1438.2000"},{"key":"key\n\t\t\t\t20171012173846_B21","doi-asserted-by":"crossref","unstructured":"Arikan S, Lozano-Chiu M, Paetznick V et al. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother2001; 45: 327\u201330.","DOI":"10.1128\/AAC.45.1.327-330.2001"},{"key":"key\n\t\t\t\t20171012173846_B22","doi-asserted-by":"crossref","unstructured":"Bowman JC, Hicks PS, Kurtz MB et al. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother2002; 46: 3001\u201312.","DOI":"10.1128\/AAC.46.9.3001-3012.2002"},{"key":"key\n\t\t\t\t20171012173846_B23","doi-asserted-by":"crossref","unstructured":"Arikan S, Lozano-Chiu M, Paetznick V et al. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother2002; 46: 245\u20137.","DOI":"10.1128\/AAC.46.1.245-247.2002"},{"key":"key\n\t\t\t\t20171012173846_B24","doi-asserted-by":"crossref","unstructured":"Kuhn DM, Balkis M, Chandra J et al. Uses and limitations of the XTT assay in studies of candida growth metabolism. J Clin Microbiol2003; 41: 506\u20138.","DOI":"10.1128\/JCM.41.1.506-508.2003"},{"key":"key\n\t\t\t\t20171012173846_B25","doi-asserted-by":"crossref","unstructured":"Becker MJ, Dams EThM, de Marie S et al. Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats. Nucl Med Biol2002; 29: 177\u201384.","DOI":"10.1016\/S0969-8051(01)00291-8"},{"key":"key\n\t\t\t\t20171012173846_B26","doi-asserted-by":"crossref","unstructured":"Walsh TJ, McEntee C, Dixon DM. Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans. J Clin Microbiol1987; 25: 931\u20132.","DOI":"10.1128\/JCM.25.5.931-932.1987"},{"key":"key\n\t\t\t\t20171012173846_B27","doi-asserted-by":"crossref","unstructured":"Ibrahim AS, Bowman JC, Avanessian V et al. Caspofungin inhibits Rhizopus oryzae 1,3-\u03b2-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother2004; 49: 721\u20137.","DOI":"10.1128\/AAC.49.2.721-727.2005"},{"key":"key\n\t\t\t\t20171012173846_B28","doi-asserted-by":"crossref","unstructured":"Andes D. Clinical utility of antifungal pharmacokinetics and pharmacodynamics. Curr Opin Infect Dis2004; 17: 533\u201340.","DOI":"10.1097\/00001432-200412000-00005"},{"key":"key\n\t\t\t\t20171012173846_B29","doi-asserted-by":"crossref","unstructured":"Hajdu R, Thompson R, Sundelof JG et al. Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrob Agents Chemother1997; 41: 2339\u201344.","DOI":"10.1128\/AAC.41.11.2339"},{"key":"key\n\t\t\t\t20171012173846_B30","doi-asserted-by":"crossref","unstructured":"Sandhu, P, Xu X, Bondiskey PJ et al. Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys. Antimicrob Agents Chemother2004; 48: 1272\u201380.","DOI":"10.1128\/AAC.48.4.1272-1280.2004"},{"key":"key\n\t\t\t\t20171012173846_B31","doi-asserted-by":"crossref","unstructured":"Stone JA, Xu X, Winchell GA et al. Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma. Antimicrob Agents Chemother2004; 48: 815\u201323.","DOI":"10.1128\/AAC.48.3.815-823.2004"},{"key":"key\n\t\t\t\t20171012173846_B32","doi-asserted-by":"crossref","unstructured":"Stone JA, Holland SD, Wickersham PJ et al. Single- and Multiple-dose pharmacokinetics of caspofungin in healthy men. Antimicrob Agents Chemother2002; 46: 739\u201345.","DOI":"10.1128\/AAC.46.3.739-745.2002"},{"key":"key\n\t\t\t\t20171012173846_B33","doi-asserted-by":"crossref","unstructured":"Bekersky I, Fielding RM, Dressler DE et al. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother2002; 46: 828\u201333.","DOI":"10.1128\/AAC.46.3.828-833.2002"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/57\/4\/732\/1943169\/dkl015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T14:23:15Z","timestamp":1586701395000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/57\/4\/732\/669394\/Caspofungin-antifungal-activity-in-vitro"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,7]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,2,7]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkl015","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,4]]},"published":{"date-parts":[[2006,2,7]]}}}